STOP Persistent AF

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 186 participants.

Also called NCT03012841

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 186 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03012841
Other papers using this trial's data
  • Cryoballoon ablation of pulmonary veins for persistent atrial fibrillation: Results from the multicenter STOP Persistent AF trial Heart rhythm, 2020-11 DOI, PubMed 32590151

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Canada, Japan (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03012841. Allocation not applicable; no masking; primary purpose treatment. Start 2017-03-02 (actual); primary completion 2019-08-13 (actual). Results posted on 2020-08-21.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
STOP Persistent AF
Intervention (Device)
Arctic Front Advance Cardiac CryoAblation Catheter
Lead sponsor
Medtronic Cardiac Ablation Solutions (class: industry)

Record details

Record id
cardio:ct-nct03012841
Content hash
5cea6d14f3a8b3ebc85cbd523c81b944c9840f6468878e738c4adf597f64f930